Navigation Links
Scientists demonstrate laser with controlled polarization
Date:4/13/2009

Cambridge, Mass. April 13, 2009 Applied scientists at the Harvard School of Engineering and Applied Sciences (SEAS) in collaboration with researchers from Hamamatsu Photonics in Hamamatsu City, Japan, have demonstrated, for the first time, lasers in which the direction of oscillation of the emitted radiation, known as polarization, can be designed and controlled at will. The innovation opens the door to a wide range of applications in photonics and communications. Harvard University has filed a broad patent on the invention.

Spearheaded by graduate student Nanfang Yu and Federico Capasso, Robert L. Wallace Professor of Applied Physics and Vinton Hayes Senior Research Fellow in Electrical Engineering, both of SEAS, and by a team at Hamamatsu Photonics headed by Dr. Hirofumi Kan, General Manager of the Laser Group, the findings will be published as a cover feature of the April 13 issue of Applied Physics Letters.

"Polarization is one of the key features defining a laser beam. Controlling it represents an important new step towards beam engineering of lasers with unprecedented flexibility, tailored for specific applications," explains Capasso. "The novelty of our approach is that instead of being conducted externally, which requires bulky and expensive optical components, manipulation of the beam polarization is achieved by directly integrating the polarizer on the laser facet. This compact solution is applicable to semiconductor lasers and other solid-state lasers, all the way from communication wavelengths to the mid-infrared and Terahertz spectrum".

Light sources with a desirable polarization state are useful for a wide variety of applications. For example, satellite communications use two orthogonal polarizations to double the capacity of the channel; circularly-polarized light sources are necessary to detect certain biomolecules; and laser sources with a variety of polarization states have relevance for quantum cryptograph
'/>"/>

Contact: Michael Patrick Rutter
mrutter@seas.harvard.edu
617-496-3815
Harvard University
Source:Eurekalert  

0

GOOD

Page: 1 2

Related biology technology :

1. Gladstone scientists uncover potential mechanism of memory loss in Alzheimers disease
2. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
3. Social Network for Scientists Marks Ten Years Online
4. Scientists synthesize memory in yeast cells
5. Scientists synthesize memory in yeast cells
6. University of Leicester scientists discover technique to help friendly bacteria
7. Scientists discover how cancer may take hold
8. Yale scientists make 2 giant steps in advancement of quantum computing
9. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
10. Scientists say sabercat bit like a pussycat
11. New Corporate Website Launched - Focus on Life Scientists, Flow Cytometrists, & Clinicians
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists demonstrate laser with controlled polarization
(Date:5/20/2013)... , May 20, 2013 Pacific Biomarkers and ... solutions for developers of biosimilars at the 2013 ... Sheraton San Diego Hotel and Marina ... will have the opportunity to speak with company representatives ... Paths That Cross" on May 21 from 1-2 p.m. ...
(Date:5/20/2013)... 20, 2013 Cempra, Inc. (Nasdaq: CEMP), ... antibiotics to meet critical medical needs in the ... presented data at the American Thoracic Society International ... demonstrating the antibacterial and enhanced immunomodulatory activity ... 2 clinical trial in outpatients with community acquired ...
(Date:5/20/2013)... Pittsburgh, PA (PRWEB) May 20, 2013 ... the Allegheny General Hospital (AGH) Cardiovascular Institute ... of coronary artery disease (CAD) over the ... procedures such as balloon angioplasty and coronary artery stent ... will once again play a prominent role in the ...
(Date:5/20/2013)... May 20, 2013 On 25-28 July, ... – in Paris - the beautiful city of lights. ... "Personalized Medicine is revolutionizing the medical world. Understanding and ... is the hallmark of this transformation. Much of the ... from the epidemiologic studies of large cohorts that do ...
Breaking Biology Technology:Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris 2
... (Nasdaq:,INSM), today announced that it has been awarded ... (MDA). The grant is expected to cover a,substantial ... 24-week,Phase 3 enabling trial in patients with Myotonic ... biopharmaceutical company with extensive,expertise in biologics and orphan ...
... Filed With the FDA for the Fourth Genmab Antibody ... the Company,s Collaboration with Roche., COPENHAGEN, December 12 ... New Drug application (IND) for a,Genmab antibody developed under ... FDA by Roche. Genentech and Roche are collaborating on,development ...
... Toronto Stock Exchange Symbol: MS, EDMONTON, Dec. ... leading developer in the treatment of multiple sclerosis ... Board (DSMB) has,reviewed data from the Company,s on-going ... for the treatment of secondary progressive MS and,recommended ...
Cached Biology Technology:Insmed Awarded $2.1 Million by Muscular Dystrophy Association 2Insmed Awarded $2.1 Million by Muscular Dystrophy Association 3Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic 2Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic 3BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2
(Date:5/17/2013)... for Experimental Biology (FASEB) released a new analysis ... highlighting the devastating impact of sequestration on the nation,s ... a May 15th Senate Appropriations Committee hearing featuring NIH ... $1.6 billion cut the agency sustained in FY 2013 ... the scientific community." , According to data from ...
(Date:5/16/2013)... Bethesda, MD FASEB MARC (Maximizing Access to ... recipients for The Society for Developmental Biology (SDB) ... 16-20, 2013. These awards are meant to promote ... underrepresented groups into the mainstream of the basic ... young scientists at the SDB 2013 Annual Meeting. ...
(Date:5/16/2013)... Injectable nanoparticles developed at MIT may someday eliminate ... to constantly monitor their blood-sugar levels and inject ... to sense glucose levels in the body and ... thereby replacing the function of pancreatic islet cells, ... diabetes. Ultimately, this type of system could ensure ...
Breaking Biology News(10 mins):Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3
... post doctoral fellow Virginie Mieulet, in the Faculty of Medicine ... is so vital in fighting infection. , They have discovered ... body know that it,s being attacked by an infection. , ... could have implications for the millions of people in third ...
... Trypanosomes are parasites responsible for many human and ... parasites cause, African sleeping sickness, results from the bite ... at risk in 36 sub-Saharan countries. The recent 1998-2001 ... of Congo and Uganda killed tens of thousands of ...
... A team led by Massachusetts General Hospital (MGH) scientists ... accurately isolating neutrophils the most abundant type of ... accomplishment that could provide information essential to better understanding ... system, described in a Nature Medicine paper ...
Cached Biology News:New research shows how disease-causing parasite gets around human innate immunity 2New research shows how disease-causing parasite gets around human innate immunity 3New research shows how disease-causing parasite gets around human innate immunity 4Microfluidic device allows collection, analysis of hard-to-handle immune cells 2
... This immunoaffinity purified antibody detects an ... molecular mass of ErbB-2 phosphorylated at tyrosine ... product has been cross adsorbed against the ... detect the non-phosphorylated form of the protein. ...
Anti-GOSR2 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunocytochemistry, Immunoprecipitation, Western Blot...
... Synthetic peptide corresponding ... Antigen Family: ... Antigen Subfamily: not ... Recommended Storage: Long ...
Anti-DNA Polymerase a, Human Description: 50 l Research Focus: cancer & cell proliferation Storage: 4C Shipping Temperature: 4C...
Biology Products: